Literature DB >> 19236611

Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.

Simone M Flight1, Lambro A Johnson, Qianyun S Du, Roscoe L Warner, Manuela Trabi, Patrick J Gaffney, Martin F Lavin, John de Jersey, Paul P Masci.   

Abstract

Aprotinin has been used widely in surgery as an anti-bleeding agent but is associated with a number of side effects. We report that textilinin-1, a serine protease inhibitor from Pseudonaja textilis venom with sequence relatedness to aprotinin, is a potent but reversible plasmin inhibitor and has a narrower range of protease inhibition compared to aprotinin. Like aprotinin, textilinin-1 at 5 micromol/l gave almost complete inhibition of tissue plasminogen activator-induced fibrinolysis of whole blood clots. The activated partial thromboplastin time for plasma was markedly increased by aprotinin but unaffected by textilinin-1. In a mouse tail-vein bleeding model, intravenous textilinin-1 and aprotinin caused similar decreases in blood loss but time to haemostasis in the textilinin-treated animals was significantly shorter than in aprotinin-treated mice. Based on these data, textilinin-1 merits further investigation as a therapeutic alternative to aprotinin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236611     DOI: 10.1111/j.1365-2141.2009.07605.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

Review 1.  Antifibrinolytic Therapy and Perioperative Considerations.

Authors:  Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal:  Anesthesiology       Date:  2018-03       Impact factor: 7.892

2.  S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin.

Authors:  K Vadivel; Y Kumar; G I Ogueli; S M Ponnuraj; P Wongkongkathep; J A Loo; M S Bajaj; S P Bajaj
Journal:  J Thromb Haemost       Date:  2016-11-19       Impact factor: 5.824

3.  Purification and characterization of tenerplasminin-1, a serine peptidase inhibitor with antiplasmin activity from the coral snake (Micrurus tener tener) venom.

Authors:  Jeilyn Vivas; Carlos Ibarra; Ana M Salazar; Ana G C Neves-Ferreira; Elda E Sánchez; Jonás Perales; Alexis Rodríguez-Acosta; Belsy Guerrero
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-09-28       Impact factor: 3.228

4.  Antifibrinolytic role of a bee venom serine protease inhibitor that acts as a plasmin inhibitor.

Authors:  Young Moo Choo; Kwang Sik Lee; Hyung Joo Yoon; Yuling Qiu; Hu Wan; Mi Ri Sohn; Hung Dae Sohn; Byung Rae Jin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

Review 5.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

6.  Targeting anticoagulant protein S to improve hemostasis in hemophilia.

Authors:  Raja Prince; Luca Bologna; Mirko Manetti; Daniela Melchiorre; Irene Rosa; Natacha Dewarrat; Silvia Suardi; Poorya Amini; José A Fernández; Laurent Burnier; Claudia Quarroz; Maria Desiré Reina Caro; Yasuhiro Matsumura; Johanna A Kremer Hovinga; John H Griffin; Hans-Uwe Simon; Lidia Ibba-Manneschi; François Saller; Sara Calzavarini; Anne Angelillo-Scherrer
Journal:  Blood       Date:  2018-01-09       Impact factor: 25.476

Review 7.  Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals.

Authors:  Caroline B F Mourão; Elisabeth F Schwartz
Journal:  Mar Drugs       Date:  2013-06-14       Impact factor: 5.118

Review 8.  Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Med Res Rev       Date:  2014-03-21       Impact factor: 12.944

9.  The structure of human microplasmin in complex with textilinin-1, an aprotinin-like inhibitor from the Australian brown snake.

Authors:  Emma-Karin I Millers; Lambro A Johnson; Geoff W Birrell; Paul P Masci; Martin F Lavin; John de Jersey; Luke W Guddat
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase inhibitor.

Authors:  Hu Wan; Kwang Sik Lee; Bo Yeon Kim; Feng Ming Zou; Hyung Joo Yoon; Yeon Ho Je; Jianhong Li; Byung Rae Jin
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.